Investor Relations

everything you need to make informed investment decisions

recent releases
View all
Jul 17, 2024
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

Press release

- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif. , July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC: YTEN ) (“Yield10” or the

events & presentations
View all
May 17, 2024
Investor Slide Deck May 2024
Apr 1, 2024 4:30 PM EDT
Yield10 Bioscience Fourth Quarter 2023 Earnings Call
Mar 14, 2024
ABLC 2024 Presentation by Kristi Snell
recent sec filings
View all
 

EFFECT

external link icon

Report of unscheduled material events or corporate event

external link icon

25-NSE

external link icon

Report of unscheduled material events or corporate event

external link icon